| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 4.99B | 5.20B | 4.38B | 2.49B | 2.17B | 1.99B |
| Gross Profit | 3.04B | 3.08B | 2.91B | 2.26B | 2.00B | 1.85B |
| EBITDA | 1.41B | 1.45B | 1.31B | 865.13M | 614.50M | 306.12M |
| Net Income | 1.02B | 952.97M | 844.79M | 560.20M | 1.33B | 317.12M |
Balance Sheet | ||||||
| Total Assets | 131.73B | 121.97B | 113.01B | 107.51B | 107.58B | 96.25B |
| Cash, Cash Equivalents and Short-Term Investments | 13.12B | 18.01B | 16.11B | 13.35B | 24.02B | 16.07B |
| Total Debt | 10.17B | 9.71B | 20.14B | 6.43B | 7.74B | 7.57B |
| Total Liabilities | 125.52B | 116.09B | 107.69B | 102.60B | 102.73B | 91.29B |
| Stockholders Equity | 6.21B | 5.88B | 5.32B | 4.90B | 4.85B | 4.96B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 1.79B | 568.04M | -8.11B | 6.98B | 8.45B |
| Operating Cash Flow | 0.00 | 1.94B | 658.42M | -8.03B | 7.05B | 8.54B |
| Investing Cash Flow | 0.00 | -120.80M | -44.23M | -234.05M | -63.91M | -120.86M |
| Financing Cash Flow | 0.00 | -262.44M | -105.81M | -752.85M | 341.85M | 219.82M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | €100.84B | 9.79 | 18.66% | 4.11% | 5.66% | 8.16% | |
76 Outperform | $6.17B | 9.86 | 8.76% | 6.70% | -9.39% | 45.60% | |
76 Outperform | €64.98B | 10.97 | 15.73% | 5.03% | -7.50% | 12.76% | |
75 Outperform | €11.80B | 11.42 | 16.71% | 4.32% | -7.12% | 15.96% | |
73 Outperform | £130.83B | 9.71 | 12.91% | 2.04% | -16.49% | 14.32% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% |